Symptomatic Obstructive Hypertrophic Cardiomyopathy

4 total trials 1 recruiting

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

A study of aficamten (CK-3773274) in a Pediatric Population with Symptomatic Obstructive Hypertrophic Cardiomyopathy Recruiting

2024-511377-30-00 10 2025-01-23
A Study of Mavacamten in Adolescent Participants with Symptomatic Obstructive Hypertrophic Cardiomyopathy Recruitment ended

2023-505650-17-00 5 2024-08-27
A trial to compare the efficacy and safety of aficamten (CK-3773274) compared with metoprolol succinate in adults with symptomatic hypertrop … Ended

2023-504809-37-00 5 2024-02-07
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 11

Showing 1–4 of 4 trials